HRS-5817

Asset

Investigational therapy for obesity

Stage
Phase 1
Modality
Peptide
Target
Not known
2
Indications
2
Trials
2
Developers

2 trials are still running. Trial NCT07238647 updated in its registry on May 12, 2026. clinicaltrials.gov

Indications

2

In the full profile

  • Owner and partners2
  • Trials2
  • Competitors12
  • Aging relevance1
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets